Piolax, Inc. · TSE:5988
Piolax — H1 FY2025 Earnings Presentation
18 slides from Piolax's earnings presentation, Dec 4, 2025
Slide 1: Financial Results Briefing, December 4, 2025
Thursday, December 4, 2025 PIOLAX, INC. (Code: 5988) Satoshi Yamada, President
Slide 2: Contents
Contents 1. Medium- to Long-Term Plan ／Fiscal Year Ending March 2025 Financial Results 2. Medical Device Business 3. Capital Policy 2
Slide 3: Medium- to Long-Term Sales Plan
Medium- to Long-Term Sales Plan ✓ In FY25, the challenging business environment persists, reflecting the trends among major OEMs. ✓ Through product development that transcends the framework of existing product lines, efficiency gains from organizational restructuring, and productivity improvements d
Slide 4: FY25 1st Half Consolidated Financial Summary
FY25 1st Half Consolidated Financial Summary ✓ 1st half: Decreased revenue and profit compared to the same period last year, but roughly in line with the plan. ✓ 2nd half: Securing profit through expense control, thorough rationalization, and cost collection from customers. FY24 FY25 FY25 Japan, the
Slide 5: Product Strategy: Existing Products
Product Strategy Capture market needs through existing technologies and CASE products and create high value-added products • Solid foundation – applied in new models of most JPN OEMs New products utilizing Organizational and Tier 1 manufacturers. conventional technologies reform • Develop new produc
Slide 6: Product Development Combining Existing Technologies
Product Development Combining Existing Technologies Key points in developing new products Larger/Smaller - Evolve “connecting” beyond conventional product lines and “connect" CASE parts parts Composite with end users unit parts Electric parts • Challenges to larger products - from palm-sized to larg
Slide 7: CASE Products
CASE Products ✓ The sales expansion target for the 1st half has been achieved. To achieve 10 billion yen in sales by FY2030, we will invest our resources to enhance sales activities and product technology development. Damping stoppers Electric latch Overwhelmingly lighter, quieter, and less Electric
Slide 8: Regional Strategy
Regional Strategy 1) Review business structure (sales, development). ¥ mil 1H sales 2) Consider sales scheme for vehicles made in South America. 10,000 3) Promote selling products to other models and enter new 7,500 fields (pursuing value-added products). 5,000 2,500 • Increase sales Reduced sales a
Slide 9: Regional Strategy
Regional Strategy • Enhance sales to Maruti Suzuki and local OEMs. ¥ mil. 1H sales 1,200 • Increase production capacity by building a second plant. 900 • Active • Expand the product size we handle for larger sales. 600 investment in • Further promote motorcycle products. 300 the growing • 自動車生産工場MAP
Slide 10: Special Improvement Activities
Special Improvement Activities ✓ Under a challenging business environment, a reform promotion project directly under the president has been launched since this June to improve profitability by advancing both top-line growth and cost structure reform. Each department reviews processes from scratch to
Slide 11: Contents
Contents 1. Medium- to Long-Term Plan ／Fiscal Year Ending March 2025 Financial Results 2. Medical Device Business 3. Capital Policy 11
Slide 12: FY25 1st Half Financial Summary - Medical Device Business
FY25 1st Half Financial Summary - Medical Device Business （¥100 mil.） Medium- to Long-Term Plan ✓ Both sales and operating profit are as 150 15% planned. 売上高 Sales 営業利益率 Operating profit ratio Unit: FY24 FY25 100 Gap ¥100 mil. 1H results 1H results 100 10% 10% 68 Sales 26 25 ▲１ 51 58 6% 6% 52 50 3%
Slide 13: Contents
Contents 1. Medium- to Long-Term Plan ／Fiscal Year Ending March 2025 Financial Results 2. Medical Device Business 3. Capital Policy 13
Slide 14: Capital Policy
Capital Policy Cumulative share buyback of 30 billion yen over three years ✓ Market purchases were conducted from May 13 to November 18, 2025, with additional 2 billion yen acquired. ✓ Together with the market purchases of 2.6 billion yen from November 2024 and the TOB of 21.7 billion yen in Februar
Slide 15: Appendix
Appendix PIOLAX Connect people and society with technology for an exciting future 15
Slide 16: New Head Office / Moka Plant
New Head Office / Moka Plant New Head Office <Iwai-cho, Hodogaya-ku, Yokohama-shi, Kanagawa> • Completed in August 2025 • Move-in started at the end of September • Operation started from October Taking this opportunity, we will pursue workstyle transformation and productivity improvement. New Moka P
Slide 17: Sustainability Initiatives
Sustainability Initiatives Carbon neutrality status ✓ We are achieving our goal ahead of schedule. (t-CO2) Piolax Group carbon neutrality targets and results 50,000 BM44,772 10% 13% 17% 20% 40,000 30,000 46% 20,000 43% reduced 70% (From FY2019) 85% 10,000 0 0 2019 2020 2021 2022 2023 2024 2025 2030
Slide 18: Precaution for Handling This Document
Precaution for Handling This Document The forward-looking statements regarding our company in this document are based on information currently available to us. Please note that they are only projections at this time containing risks and uncertainties, and actual results may differ significantly from